Search Page

1

Cite

Share

The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test.

Kewenter J, Brevinge H, Engarås B, Haglind E. Kewenter J, et al. Endoscopy. 1995 Feb;27(2):159-63. doi: 10.1055/s-2007-1005655. Endoscopy. 1995. PMID: 7601048

Cite

Share

2

Cite

Share

Diagnostic accuracy of double-contrast enema and rectosigmoidoscopy in connection with faecal occult blood testing for the detection of rectosigmoid neoplasms.

Jensen J, Kewenter J, Haglind E, Lycke G, Svensson C, Ahrén C. Jensen J, et al. Among authors: kewenter j. Br J Surg. 1986 Dec;73(12):961-4. doi: 10.1002/bjs.1800731206. Br J Surg. 1986. PMID: 3790958

Cite

Share

3

Cite

Share

Value of a risk questionnaire in screening for colorectal neoplasm.

Kewenter J, Haglind E, Smith L. Kewenter J, et al. Br J Surg. 1989 Mar;76(3):280-3. doi: 10.1002/bjs.1800760321. Br J Surg. 1989. PMID: 2720326

Cite

Share

4

Cite

Share

Perception errors with double-contrast enema after a positive guaiac test.

Kewenter J, Jensen J, Boijsen M, Lycke G, Tylén U. Kewenter J, et al. Gastrointest Radiol. 1987;12(1):79-82. doi: 10.1007/BF01885109. Gastrointest Radiol. 1987. PMID: 3792765

Cite

Share

5

Cite

Share

Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population.

Brevinge H, Lindholm E, Buntzen S, Kewenter J. Brevinge H, et al. Among authors: kewenter j. Int J Colorectal Dis. 1997;12(5):291-5. doi: 10.1007/s003840050108. Int J Colorectal Dis. 1997. PMID: 9401844 Clinical Trial.

Cite

Share

6

Cite

Share

CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.

Engarås B, Kewenter J, Nilsson O, Wedel H, Hafström L. Engarås B, et al. Among authors: kewenter j. Eur J Surg Oncol. 2001 Feb;27(1):43-8. doi: 10.1053/ejso.2000.1027. Eur J Surg Oncol. 2001. PMID: 11237491

Cite

Share

7

Cite

Share

[Colorectal cancer mortality can be reduced. Fecal blood screening is an efficient test].

Kewenter J. Kewenter J. Lakartidningen. 1998 Jun 17;95(25):2950-2. Lakartidningen. 1998. PMID: 9674365 Review. Swedish.

Cite

Share

8

Cite

Share

Worry associated with screening for colorectal carcinomas.

Lindholm E, Berglund B, Kewenter J, Haglind E. Lindholm E, et al. Among authors: kewenter j. Scand J Gastroenterol. 1997 Mar;32(3):238-45. doi: 10.3109/00365529709000201. Scand J Gastroenterol. 1997. PMID: 9085461 Clinical Trial.

Cite

Share

9

Cite

Share

Endoscopic and surgical complications of work-up in screening for colorectal cancer.

Kewenter J, Brevinge H. Kewenter J, et al. Dis Colon Rectum. 1996 Jun;39(6):676-80. doi: 10.1007/BF02056949. Dis Colon Rectum. 1996. PMID: 8646956 Clinical Trial.

Cite

Share

10

Cite

Share

Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial.

Kewenter J, Brevinge H, Engarås B, Haglind E, Ahrén C. Kewenter J, et al. Dis Colon Rectum. 1994 Feb;37(2):115-9. doi: 10.1007/BF02047531. Dis Colon Rectum. 1994. PMID: 8306829 Clinical Trial.

Cite

Share